News
Peptide news & updates
Follow regulatory developments, research context, and educational explainers without leaving the peptide review cycle to rumor.
regulatory
FDA Announces July 2026 Advisory Committee for Peptide Review
The FDA will convene its Pharmacy Compounding Advisory Committee on July 23-24, 2026 to discuss seven peptides and whether they belong on the 503A bulks list.
Read more →
research
BPC-157: What the Research Shows About Gut Healing
BPC-157 remains one of the most discussed regenerative peptides, but the research story is strongest in gastrointestinal protection and ulcerative colitis-related models.
Read more →
education
Research Peptides vs Medical-Grade: Understanding the Difference
The biggest safety variable in peptide therapy is often not the peptide itself, but the quality controls around sourcing, compounding, and physician oversight.
Read more →